119 related articles for article (PubMed ID: 15566413)
1. Large fontanelles are a shared feature of haploinsufficiency of RUNX2 and its co-activator CBFB.
Goto T; Aramaki M; Yoshihashi H; Nishimura G; Hasegawa Y; Takahashi T; Ishii T; Fukushima Y; Kosaki K
Congenit Anom (Kyoto); 2004 Dec; 44(4):225-9. PubMed ID: 15566413
[TBL] [Abstract][Full Text] [Related]
2. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
3. Cbfb regulates bone development by stabilizing Runx family proteins.
Qin X; Jiang Q; Matsuo Y; Kawane T; Komori H; Moriishi T; Taniuchi I; Ito K; Kawai Y; Rokutanda S; Izumi S; Komori T
J Bone Miner Res; 2015 Apr; 30(4):706-14. PubMed ID: 25262822
[TBL] [Abstract][Full Text] [Related]
4. Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcome.
Khan A; Hyde RK; Dutra A; Mohide P; Liu P
Am J Med Genet A; 2006 Nov; 140(21):2349-54. PubMed ID: 17022082
[TBL] [Abstract][Full Text] [Related]
5. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
6. Deletion of 3'-CBFB gene in association with an inversion (16)(p13q22) and a loss of the Y chromosome in a 2-year-Old child with acute myelogenous leukemia-M4.
Batanian JR; Huang Y; Fallon R
Cancer Genet Cytogenet; 2000 Sep; 121(2):216-9. PubMed ID: 11063812
[TBL] [Abstract][Full Text] [Related]
7. Requisite roles of Runx2 and Cbfb in skeletal development.
Komori T
J Bone Miner Metab; 2003; 21(4):193-7. PubMed ID: 12811622
[TBL] [Abstract][Full Text] [Related]
8. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
[TBL] [Abstract][Full Text] [Related]
9. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.
Lee B; Thirunavukkarasu K; Zhou L; Pastore L; Baldini A; Hecht J; Geoffroy V; Ducy P; Karsenty G
Nat Genet; 1997 Jul; 16(3):307-10. PubMed ID: 9207800
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous pathogenic variants involving
Beyltjens T; Boudin E; Revencu N; Boeckx N; Bertrand M; Schütz L; Haack TB; Weber A; Biliouri E; Vinkšel M; Zagožen A; Peterlin B; Pai S; Telegrafi A; Henderson LB; Ells C; Turner L; Wuyts W; Van Hul W; Hendrickx G; Mortier GR
J Med Genet; 2023 May; 60(5):498-504. PubMed ID: 36241386
[TBL] [Abstract][Full Text] [Related]
11. Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development.
Smith N; Dong Y; Lian JB; Pratap J; Kingsley PD; van Wijnen AJ; Stein JL; Schwarz EM; O'Keefe RJ; Stein GS; Drissi MH
J Cell Physiol; 2005 Apr; 203(1):133-43. PubMed ID: 15389629
[TBL] [Abstract][Full Text] [Related]
12. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 16 inversion-associated translocations in acute myeloid leukemia elucidated using a dual-color CBFB DNA probe.
Aventín A; Espadaler M; Casas S; Duarte J; Nomdedéu J; Sierra J
Cancer Genet Cytogenet; 2002 Apr; 134(2):142-4. PubMed ID: 12034528
[TBL] [Abstract][Full Text] [Related]
14. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
15. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.
Otto F; Kanegane H; Mundlos S
Hum Mutat; 2002 Mar; 19(3):209-16. PubMed ID: 11857736
[TBL] [Abstract][Full Text] [Related]
17. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
18. Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development.
Kanatani N; Fujita T; Fukuyama R; Liu W; Yoshida CA; Moriishi T; Yamana K; Miyazaki T; Toyosawa S; Komori T
Dev Biol; 2006 Aug; 296(1):48-61. PubMed ID: 16797526
[TBL] [Abstract][Full Text] [Related]
19. Core binding factor β of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice.
Lim KE; Park NR; Che X; Han MS; Jeong JH; Kim SY; Park CY; Akiyama H; Kim JE; Ryoo HM; Stein JL; Lian JB; Stein GS; Choi JY
J Bone Miner Res; 2015 Apr; 30(4):715-22. PubMed ID: 25358268
[TBL] [Abstract][Full Text] [Related]
20. Different Requirements of CBFB and RUNX2 in Skeletal Development among Calvaria, Limbs, Vertebrae and Ribs.
Jiang Q; Qin X; Nagano K; Komori H; Matsuo Y; Taniuchi I; Ito K; Komori T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
